Validated technology in peer-reviewed studies

Proven technology

We’re reshaping the future of respiratory care with simple and accurate technology that can be used by physicians and patients. Our technology has been validated in peer-reviewed studies.

At least four times a year we release updates of our solution taking into account the feedback we regularly collect from variety of sources and mechanisms including workshops, surveys and directly from users. At NuvoAir we welcome any opportunity to learn how our technology can be developed to continue to improve the lives of people living with long term conditions, their caregivers and clinical teams.

Clinical Evidence



Validation of the Technology

Real-World-Data from our cystic fibrosis engagements reveals great health economic outcome potential and staggering acceptance

Booked
Consultations

Urgent
Consultations


Improved
understanding of CF

Improved
medication adherence

ePS1.07 Patient experience of virtual consultations: survey results, Journal of Cystic Fibrosis Volume 19, Supplement 2, June 2020, Page s39

9.4

Acceptance of NuvoAir solution on a scale from 0-10

Our partners


Hospitals, universities, pharma companies and CROs around the world have chosen NuvoAir as their respiratory partner. We’re proud to support the work of forward-thinking, innovative players and researchers.

Learn more
Seattle Children's
Dartmouth-Hitchcock
NHS King's College Hospital logo
Boston Children's Hospital
Novartis logo
Roche logo
regeneron logo
NHS Royal Brompton Hospital logo

Join NuvoAir today

We work with leading pharmaceutical companies, insurance plans and healthcare systems to offer NuvoAir at no cost to people with respiratory problems. Answer a few quick questions to see how we can start your journey with NuvoAir.